Jones Financial Companies
SGMO

Jones Financial Companies’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Jones Financial Companies’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,388
Closed -$583 – 4900
2025
Q4 		$583 Hold
1,388
– – ﹤0.01% 4132
2025
Q3 		$922 Hold
1,388
– – ﹤0.01% 3918
2025
Q2 		$750 Hold
1,388
– – ﹤0.01% 3722
2025
Q1 		$1.14K Buy
+1,388
New +$1.47K ﹤0.01% 3375

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jones Financial Companies's SGMO Position: Q1 2026 in Review

Jones Financial Companies sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026, closing a stake of 1,388 shares — an estimated $583 sold.

Jones Financial Companies first reported a position in SGMO in Q1 2025 and held it in 4 quarters. The position peaked at $1.14K in Q1 2025. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Jones Financial Companies reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
  • Jones Financial Companies sold 1,388 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $583.
  • Jones Financial Companies first reported a position in SANGAMO THERAPEUTICS INC in Q1 2025 and held it in 4 quarters.
  • Jones Financial Companies's SANGAMO THERAPEUTICS INC position peaked at $1.14K in Q1 2025.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.